Selected research
Market Structure
Global Ocular Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ocular Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ocular Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ocular Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ocular Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ocular Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ocular Excipients include Abitec, BASF, Beneo, Croda Health Care, DFE Pharma, Evonik, Farmigea, Fuji Chemical Industry and JRS Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ocular Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ocular Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ocular Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ocular Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.
Ocular Excipients Segment by Company
Abitec
BASF
Beneo
Croda Health Care
DFE Pharma
Evonik
Farmigea
Fuji Chemical Industry
JRS Pharma
Lubrizol Corporation
Perkin Elmer
Pfanstiehl
Merck Group
Ocular Excipients Segment by Type
Disintegrants
Tablet Coatings and Films
Lubricants
Dilutents
Binders
Colouring Agents
Glidants
Ocular Excipients Segment by Application
Pharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Others
Ocular Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ocular Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ocular Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ocular Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ocular Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ocular Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ocular Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ocular Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Disintegrants
- Tablet Coatings and Films
- Lubricants
- Dilutents
- Binders
- Colouring Agents
- Glidants
Applications
- Pharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Others
Companies covered
- Abitec
- BASF
- Beneo
- Croda Health Care
- DFE Pharma
- Evonik
- Farmigea
- Fuji Chemical Industry
- JRS Pharma
- Lubrizol Corporation
- Perkin Elmer
- Pfanstiehl
- Merck Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ocular Excipients Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ocular Excipients Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ocular Excipients Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ocular Excipients Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ocular Excipients Market Dynamics
- 2.1 Ocular Excipients Industry Trends
- 2.2 Ocular Excipients Industry Drivers
- 2.3 Ocular Excipients Industry Opportunities and Challenges
- 2.4 Ocular Excipients Industry Restraints
3 Ocular Excipients Market by Manufacturers
- 3.1 Global Ocular Excipients Revenue by Manufacturers (2021-2026)
- 3.2 Global Ocular Excipients Sales by Manufacturers (2021-2026)
- 3.3 Global Ocular Excipients Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ocular Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ocular Excipients Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ocular Excipients Manufacturers, Product Type & Application
- 3.7 Global Ocular Excipients Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ocular Excipients Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ocular Excipients Players Market Share by Revenue in 2025
- 3.8.3 2025 Ocular Excipients Tier 1, Tier 2, and Tier 3
4 Ocular Excipients Market by Type
- 4.1 Ocular Excipients Type Introduction
- 4.1.1 Disintegrants
- 4.1.2 Tablet Coatings and Films
- 4.1.3 Lubricants
- 4.1.4 Dilutents
- 4.1.5 Binders
- 4.1.6 Colouring Agents
- 4.1.7 Glidants
- 4.2 Global Ocular Excipients Sales by Type
- 4.2.1 Global Ocular Excipients Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ocular Excipients Sales by Type (2021-2032)
- 4.2.3 Global Ocular Excipients Sales Market Share by Type (2021-2032)
- 4.3 Global Ocular Excipients Revenue by Type
- 4.3.1 Global Ocular Excipients Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ocular Excipients Revenue by Type (2021-2032)
- 4.3.3 Global Ocular Excipients Revenue Market Share by Type (2021-2032)
5 Ocular Excipients Market by Application
- 5.1 Ocular Excipients Application Introduction
- 5.1.1 Pharmaceutical Companies
- 5.1.2 Contract Manufacturing Organizations (CMOs)
- 5.1.3 Others
- 5.2 Global Ocular Excipients Sales by Application
- 5.2.1 Global Ocular Excipients Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ocular Excipients Sales by Application (2021-2032)
- 5.2.3 Global Ocular Excipients Sales Market Share by Application (2021-2032)
- 5.3 Global Ocular Excipients Revenue by Application
- 5.3.1 Global Ocular Excipients Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ocular Excipients Revenue by Application (2021-2032)
- 5.3.3 Global Ocular Excipients Revenue Market Share by Application (2021-2032)
6 Global Ocular Excipients Sales by Region
- 6.1 Global Ocular Excipients Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ocular Excipients Sales by Region (2021-2032)
- 6.2.1 Global Ocular Excipients Sales by Region (2021-2026)
- 6.2.2 Global Ocular Excipients Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ocular Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ocular Excipients Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ocular Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ocular Excipients Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ocular Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ocular Excipients Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ocular Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ocular Excipients Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ocular Excipients Revenue by Region
- 7.1 Global Ocular Excipients Revenue by Region
- 7.1.1 Global Ocular Excipients Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ocular Excipients Revenue by Region (2021-2026)
- 7.1.3 Global Ocular Excipients Revenue by Region (2027-2032)
- 7.1.4 Global Ocular Excipients Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ocular Excipients Revenue (2021-2032)
- 7.2.2 North America Ocular Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ocular Excipients Revenue (2021-2032)
- 7.3.2 Europe Ocular Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ocular Excipients Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ocular Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ocular Excipients Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ocular Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abitec
- 8.1.1 Abitec Company Information
- 8.1.2 Abitec Business Overview
- 8.1.3 Abitec Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abitec Ocular Excipients Product Portfolio
- 8.1.5 Abitec Recent Developments
- 8.2 BASF
- 8.2.1 BASF Company Information
- 8.2.2 BASF Business Overview
- 8.2.3 BASF Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BASF Ocular Excipients Product Portfolio
- 8.2.5 BASF Recent Developments
- 8.3 Beneo
- 8.3.1 Beneo Company Information
- 8.3.2 Beneo Business Overview
- 8.3.3 Beneo Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Beneo Ocular Excipients Product Portfolio
- 8.3.5 Beneo Recent Developments
- 8.4 Croda Health Care
- 8.4.1 Croda Health Care Company Information
- 8.4.2 Croda Health Care Business Overview
- 8.4.3 Croda Health Care Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Croda Health Care Ocular Excipients Product Portfolio
- 8.4.5 Croda Health Care Recent Developments
- 8.5 DFE Pharma
- 8.5.1 DFE Pharma Company Information
- 8.5.2 DFE Pharma Business Overview
- 8.5.3 DFE Pharma Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 DFE Pharma Ocular Excipients Product Portfolio
- 8.5.5 DFE Pharma Recent Developments
- 8.6 Evonik
- 8.6.1 Evonik Company Information
- 8.6.2 Evonik Business Overview
- 8.6.3 Evonik Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Evonik Ocular Excipients Product Portfolio
- 8.6.5 Evonik Recent Developments
- 8.7 Farmigea
- 8.7.1 Farmigea Company Information
- 8.7.2 Farmigea Business Overview
- 8.7.3 Farmigea Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Farmigea Ocular Excipients Product Portfolio
- 8.7.5 Farmigea Recent Developments
- 8.8 Fuji Chemical Industry
- 8.8.1 Fuji Chemical Industry Company Information
- 8.8.2 Fuji Chemical Industry Business Overview
- 8.8.3 Fuji Chemical Industry Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Fuji Chemical Industry Ocular Excipients Product Portfolio
- 8.8.5 Fuji Chemical Industry Recent Developments
- 8.9 JRS Pharma
- 8.9.1 JRS Pharma Company Information
- 8.9.2 JRS Pharma Business Overview
- 8.9.3 JRS Pharma Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 JRS Pharma Ocular Excipients Product Portfolio
- 8.9.5 JRS Pharma Recent Developments
- 8.10 Lubrizol Corporation
- 8.10.1 Lubrizol Corporation Company Information
- 8.10.2 Lubrizol Corporation Business Overview
- 8.10.3 Lubrizol Corporation Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Lubrizol Corporation Ocular Excipients Product Portfolio
- 8.10.5 Lubrizol Corporation Recent Developments
- 8.11 Perkin Elmer
- 8.11.1 Perkin Elmer Company Information
- 8.11.2 Perkin Elmer Business Overview
- 8.11.3 Perkin Elmer Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Perkin Elmer Ocular Excipients Product Portfolio
- 8.11.5 Perkin Elmer Recent Developments
- 8.12 Pfanstiehl
- 8.12.1 Pfanstiehl Company Information
- 8.12.2 Pfanstiehl Business Overview
- 8.12.3 Pfanstiehl Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Pfanstiehl Ocular Excipients Product Portfolio
- 8.12.5 Pfanstiehl Recent Developments
- 8.13 Merck Group
- 8.13.1 Merck Group Company Information
- 8.13.2 Merck Group Business Overview
- 8.13.3 Merck Group Ocular Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Merck Group Ocular Excipients Product Portfolio
- 8.13.5 Merck Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ocular Excipients Value Chain Analysis
- 9.1.1 Ocular Excipients Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ocular Excipients Production Mode & Process
- 9.2 Ocular Excipients Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ocular Excipients Distributors
- 9.2.3 Ocular Excipients Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst